FNY Investment Advisers »

Adicet Bio Ord shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 6.1k 8.36

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp (FCRS.U)
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Adicet Bio Ord

Franklin Resources
Vanguard Group
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Acadian Asset Management
ADAR1 Capital Management
Geode Capital Management
Luminus Management
State Street Corporation
Barclays
GSA Capital Partners
FNY Investment Advisers
UBS Group

View all funds holding Adicet Bio Ord